If youre leaning toward NAD+ therapy, contact our team to schedule a consultation
As an important stakeholder in healthcare, health insurers should play their part in ensuring that GLP-1s, like all other treatments, are being utilized responsibly and at prices that enable financially sustainable treatment plans for the ongoing benefit of all
Journal of Neuroscience Research, 88(15), 3275-3281
There could be a rationale for limiting the NMA to a within class comparison of GLP-1 agonists if the manufacturer was advocating for semaglutide as the best-in-class agent
PlexusDx serves all 50 states with no insurance required, and your medication is HSA/FSA eligible, giving you direct access to prescription-strength GLP-1 therapy without membership fees
Improves mitochondrial function and detoxification